Biological Information
Background Information:
PTPRF, protein tyrosine phosphatase, receptor type, F (LAR or leukocyte common antigen-related molecule;) is a phospho tyrosine-specific protein phosphatase. Human LAR is expressed in various cell lineages such as epithelial cells, smooth muscle cells, and cardiac myocytes, but not in the spleen, brain, or neurons. Physiological function for LAR in cellular signalling by tyrosine dephosphorylation is responsive to cell-cell or cell-matrix interactions. An LAR inhibitor may be useful in the treatment of insulin resistance.
Family:
Phosphatase
Sub Family:
RTP
Class:
Protein Tyrosine
Protein Name:
LAR
Uniprot Number:
P10586
Gene Name:
PTPRF
Gene ID:
5792
Accession Number:
NM_001329137
Organism:
Human
Construct Details:
Fragment, Recombinant
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Functional Mode:
Antagonist
Detection Method:
Spectrofluorimetry
Measured Response:
Fluorescence
Testing Information
Procedure Summary:
Human recombinant protein phosphatase LAR expressed in E. coli is used. Test compound and/or vehicle is preincubated with 0.48 ng/ml enzyme‡ for 15 minutes at 37°C in modified HEPES buffer pH 7.2. The reaction is initiated by addition of 10 μM DiFMUP for 60 minutes. Determination of the amount of DiFMU formed is read spectrofluorimetrically at 358 nm/450 nm. Compounds are screened at 10 μM.
Substrate:
10 µM DiFMUP
Incubation:
60 min at 37°C
Control Inhibitor:
(NH₄)₆Mo₇O₂₄
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Adverse / Beneficial Action:
An LAR inhibitor may be useful in the treatment of insulin resistance.
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei